Assembly Biosciences, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2019
Total Assets: $339.9M
Liabilities Breakdown FY2019
Total Liabilities: $66.7M
Asset Breakdown
Total Assets: $339.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $46.7M | 13.7% |
| Accounts Receivable | $3.4M | 1.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $1.8M | 0.5% |
| Goodwill | $12.6M | 3.7% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $275.3M | 81.0% |
Liabilities Breakdown
Total Liabilities: $66.7M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.7M | 2.6% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $65.0M | 97.4% |